- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Dihydrouracil Dehydrogenase (NADP)
Total 1140 results
-
Georgetown UniversityAbbottCompletedColorectal CancerUnited States
-
SanofiCompleted
-
Gustave Roussy, Cancer Campus, Grand ParisDaiichi SankyoRecruitingAdvanced Breast Cancer | HER2-positive Metastatic Breast Cancer | Breast Cancer Metastatic | HER2 Low Breast CarcinomaFrance
-
National Cancer Institute (NCI)RecruitingBreast Neoplasms | Colorectal NeoplasmsUnited States
-
Zhonglin HaoClovis Oncology, Inc.Active, not recruitingSmall Cell Lung CancerUnited States
-
Hoffmann-La RocheCompletedBreast Cancer | Ovarian Cancer | Prostate CancerUnited States, Korea, Republic of, Italy, Australia, Spain
-
zr Pharma & GmbHCompletedMetastatic Castration Resistant Prostate CancerUnited States
-
SanofiCompleted
-
National Cancer Institute (NCI)Completed
-
AbbottCompletedSolid Tumor CancersUnited States
-
Stefania La Grutta, MDCompletedAllergic RhinitisItaly
-
AstraZenecaMerck Sharp & Dohme LLC; Iqvia Pty LtdCompletedMalignant Solid TumorBelgium
-
Georgetown UniversityAbbottTerminated
-
Maimónides Biomedical Research Institute of CórdobaMERCK SHARP & DOHME DE ESPAÑA S.A.Not yet recruitingInfections, CytomegalovirusSpain
-
Assistance Publique - Hôpitaux de ParisRecruitingPregnant Women | CMV Infected FetusesFrance
-
Leiden University Medical CenterUniversity Medical Center Groningen; Erasmus Medical CenterRecruitingBRCA1 Mutation | BRCA2 Mutation | Homologous Recombination Deficiency | Ovarian Neoplasm EpithelialNetherlands
-
Memorial Sloan Kettering Cancer CenterRecruitingBreast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | TNBC - Triple-Negative Breast CancerUnited States
-
Merck Sharp & Dohme LLCCompleted
-
CanariaBio Inc.Veristat, LLCActive, not recruitingPeritoneal Cancer | Recurrent Ovarian Cancer | Recurrent Fallopian Tube Cancer | Recurrent Epithelial Cancer of Ovary | Recurrent Epithelial Ovarian Cancer | Recurrent Carcinoma of Ovary | Adenocarcinoma of OvaryUnited States
-
Mylin A. Torres, MDPfizer; Genentech, Inc.; Emory UniversityTerminatedBreast Cancer | Triple Negative Breast CancerUnited States
-
Emory UniversityNational Cancer Institute (NCI); GlaxoSmithKline; National Institutes of Health...Active, not recruitingMicrosatellite Stable | Stage IV Colorectal Cancer AJCC v8 | RAS Wild Type | MSI-H Colorectal Cancer | Metastatic Microsatellite Stable Colorectal Carcinoma | Advanced Microsatellite Stable Colorectal CarcinomaUnited States
-
AbbVieCompletedBreast Cancer | Hepatocellular Carcinoma | Ovarian Cancer | Fallopian Tube Cancer | Metastatic Melanoma | Primary Peritoneal Cancer | Non-hematologic Malignancies
-
AbbVie (prior sponsor, Abbott)CompletedLocally Advanced Rectal CancerUnited States, Australia
-
AHS Cancer Control AlbertaAbbott; Tom Baker Cancer CentreCompleted
-
National Cancer Institute (NCI)WithdrawnStage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Stage IV Non-Small Cell Lung Cancer | Metastatic Pancreatic Adenocarcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast... and other conditions
-
Prestwick PharmaceuticalsCompletedHuntington's Disease
-
Nader SanaiBeiGene; Barrow Neurological Institute; Ivy Brain Tumor CenterRecruitingGlioblastoma | Glioblastoma Multiforme | Glioblastoma Multiforme, AdultUnited States
-
Dana-Farber Cancer InstituteAstraZeneca; Cyclacel Pharmaceuticals, Inc.Active, not recruiting
-
University of ChicagoBristol-Myers Squibb; Clovis Oncology, Inc.TerminatedProstate Cancer | Endometrial CancerUnited States
-
Tesaro, Inc.Completed
-
National Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Breast Carcinoma | Ovarian Carcinoma | Pancreatic Carcinoma | Prostate Carcinoma | Recurrent Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative... and other conditionsUnited States
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic Obstructive
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingCytomegalovirus InfectionFrance
-
AstraZenecaCompletedGastric CancerKorea, Republic of, Japan, China, Taiwan
-
University of WashingtonAstraZenecaTerminatedCastration-Resistant Prostate Carcinoma | Prostate AdenocarcinomaUnited States
-
University of Alabama at BirminghamTerminatedOvarian Cancer | Resistant BRCA Wild-Type Ovarian CancerUnited States
-
Chongqing University Cancer HospitalRecruiting
-
AstraZenecaCompleted
-
National Cancer Institute (NCI)CompletedSolid Tumors | LymphomasUnited States
-
University of PennsylvaniaMerck Sharp & Dohme LLCRecruitingCytomegalovirus Infections | Transplant-Related DisorderUnited States
-
Virginia Commonwealth UniversityMerck Sharp & Dohme LLCRecruitingCMV | Kidney Transplant; ComplicationsUnited States
-
Rabin Medical CenterNot yet recruitingCMV | Graft-versus-host-disease
-
M.D. Anderson Cancer CenterNot yet recruitingProstate CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteMerck Sharp & Dohme LLCRecruitingOcular Melanoma | Uveal MelanomaUnited States
-
University Health Network, TorontoRecruitingEndometrial Carcinoma | P53 Mutation | Serous CarcinomaCanada
-
NCIC Clinical Trials GroupAstraZenecaCompletedColorectal CancerCanada
-
Tesaro, Inc.European Network of Gynaecological Oncological Trial Groups (ENGOT)Active, not recruitingOvarian Neoplasms | Ovarian, Fallopian Tube and Primary Peritoneal CarcinomaUnited States, Netherlands, Spain, Finland, Italy, Poland, Belgium, Canada, France, Germany, Romania, Ukraine, Norway, United Kingdom, Israel, Greece, Denmark, Belarus, Czechia
-
Peking Union Medical College HospitalZai Lab (Shanghai) Co., Ltd.Unknown
-
Memorial Sloan Kettering Cancer CenterMerck Sharp & Dohme LLCRecruitingCMV | CMV Infection | Hematopoietic Cell TransplantUnited States
-
University of Alabama at BirminghamGlaxoSmithKline; AbbVie; Breast Cancer Research Foundation of AlabamaActive, not recruitingMetastatic Triple Negative Breast CancerUnited States